SEC-sourced researchBeta
LMMY
Exousia Bio, Inc.
Company comparison ↗
Data passport
- CIK
- 0001939937
- Exchange
- OTC
- Business activity
- — · SIC 8200
- Financial inputs
- 6/6
- Filing date
- Aug 31, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| May 2024 | 11,500.0000 | Oct 17, 2025 |
| May 2025 | 3,750.0000 | Oct 17, 2025 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| May 2025 | 3,750.0000 | 51,395.0000 | -4,528.0000 | 0.0000 | 0.0000 | Oct 17, 2025 |
| May 2024 | 11,500.0000 | -25,807.0000 | -12,484.0000 | 27,453.0000 | 82,348.0000 | Oct 17, 2025 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $3.75K | May 2025 | Oct 17, 2025 | 10-K |
| Previous period revenueRevenues | $11.5K | May 2024 | Oct 17, 2025 | 10-K |
| Net incomeNetIncomeLoss | $51.4K | May 2025 | Oct 17, 2025 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$4.53K | May 2025 | Oct 17, 2025 | 10-K |
| Total assetsAssets | $0 | May 2025 | Oct 17, 2025 | 10-K |
| Total liabilitiesLiabilities | $0 | May 2025 | Oct 17, 2025 | 10-K |